Waters Introduces Mass Detector for Chromatography Separations - - BioPharm International

ADVERTISEMENT

Waters Introduces Mass Detector for Chromatography Separations


Waters QDaThe Waters ACQUITY QDa Detector is a mass detector designed to bring high-quality, mass spectral data to chromatographic separations. The detector, introduced on Oct. 7 by Waters Corp., is now shipping worldwide.

Designed as a component of a chromatographic system, the ACQUITY QDa Detector is compatible with Waters ACQUITY UltraPerformance LC, ACQUITY UltraPerformance Convergence Chromatography, Alliance high performance liquid chromatography and Waters supercritical fluid chromatography and LC-based purification systems.

The system is designed for analytical scientists who need mass spectral data without the complexity of a mass spectrometer. It features automated sample analysis and eliminates sample-specific adjustments for certainty in sample results, from user to user and system to system. The detector generates the high quality mass spectral data expected of a single quadrupole mass spectrometer in a mass detector no bigger than a photodiode array (PDA) detector.

The ACQUITY QDa Detector complements optical detection, such as the PDA detector, by confirming the identity of compounds with mass spectral information; quantifies compounds having no UV response or that are present at levels not detectable and quantifiable by optical detection, the company reports.

The ACQUITY QDa Detector is available for separations systems running Empower 2 and 3 Chromatography Data System software, including enterprise deployment with automated qualification. The ACQUITY QDa Detector is also available now for MassLynx 4.1 Mass Spectrometry Software.

Source: Waters Corp.

 

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
Author Guidelines

Click here